Name: Trump's covid-19 treatment: Is there any better approach? (en Inglés)
Price: 239149.00 COP
Availability: InStock
Author: Al-Mosawi, Aamir
ISBN: 9786138942955

portada Trump's covid-19 treatment: Is there any better approach? (en Inglés)

Formato

Libro Físico

Editorial

Scholars' Press

Autor

Al-Mosawi, Aamir

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.10 kg.

ISBN13

9786138942955

Categorías

Cuestiones generales de la medicina

Trump's covid-19 treatment: Is there any better approach? (en Inglés)

Al-Mosawi, Aamir (Autor) · Scholars' Press · Tapa Blanda

Libro Nuevo

$ 239.149

$ 398.581

Ahorras: $ 159.432

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 16 de Julio y el Jueves 25 de Julio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Trump's covid-19 treatment: Is there any better approach? (en Inglés)"

On the first of October 2020, Donald Trump tested positive for SARS-CoV-2. Most media including the CNN television channel rightly confirmed that Mr. Trump has been treated by the best doctors in the world with best therapies that could possibly help him in defeating the virus. The CNN, in various programs during the first week of October, emphasized that, American citizens with Covid-19 are not receiving the same treatments as their president. The use of a therapeutic approach including experimental antibody therapy, remdesivir and dexamethasone has not been reported as a treatment for one patient before other than Trump. In the paper we would like first to emphasize that the best doctors in the world are those who can offer the best therapies for all patients or the majority of patients, and not those who can offer treatment for one patient like Trump. Obviously, of the three important therapies, only dexamethasone can be offered to almost all the patients with covid-19. The aim of this paper is to assume that all the patients in the world are as important as Trump and tries to offer them the best evidence-based treatment.